SFI
RPTX

Susquehanna Fundamental Investments’s Repare Therapeutics RPTX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,500
Closed -$296K – 1868
2021
Q2 		$296K Hold
9,500
– – 0.01% 1374
2021
Q1 		$292K Sell
9,500
-3,029
-24% -$103K 0.01% 1301
2020
Q4 		$430K Sell
12,529
-4,771
-28% -$143K 0.01% 1155
2020
Q3 		$532K Buy
+17,300
New +$458K 0.02% 855

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Susquehanna Fundamental Investments's RPTX Position: Q3 2021 in Review

Susquehanna Fundamental Investments sold out of Repare Therapeutics (RPTX) in Q3 2021, closing a stake of 9,500 shares — an estimated $296K sold.

Susquehanna Fundamental Investments first reported a position in RPTX in Q3 2020 and held it in 4 quarters. The position peaked at $532K in Q3 2020. 66 funds tracked by Wall St. Rank hold RPTX as of Q3 2021.

  • Susquehanna Fundamental Investments reported no remaining Repare Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 9,500 Repare Therapeutics shares in Q3 2021, an estimated $296K.
  • Susquehanna Fundamental Investments first reported a position in Repare Therapeutics in Q3 2020 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's Repare Therapeutics position peaked at $532K in Q3 2020.
  • 66 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2021, filed 15 Nov 2021.